Zobrazeno 1 - 10
of 283
pro vyhledávání: '"Ronald T. Mitsuyasu"'
Autor:
Lilie L. Lin, David S. Lakomy, Elizabeth Y. Chiao, Robert M. Strother, Meg Wirth, Ethel Cesarman, Margaret Borok, Naftali Busakhala, Carla J. Chibwesha, Lameck Chinula, Ntokozo Ndlovu, Jackson Orem, Warren Phipps, Vikash Sewram, Samantha L. Vogt, Joseph A. Sparano, Ronald T. Mitsuyasu, Susan E. Krown, Satish Gopal
Publikováno v:
JCO Global Oncology, Vol , Iss 6, Pp 1134-1146 (2020)
PURPOSEThe aim of this study was to review the current status of clinical trials for HIV-associated malignancies in people living with HIV in sub-Saharan Africa (SSA) and efforts made by the AIDS Malignancy Consortium (AMC) to build capacity in SSA f
Externí odkaz:
https://doaj.org/article/79b9238cbebd496bbde3be934652fcc7
Autor:
Curtis Dobrowolski, Michael F. Para, Jonathan Karn, Joshua C. Cyktor, Edward P. Acosta, Ronald T. Mitsuyasu, Joseph Hesselgesser, Joan Dragavon, Evgenia Aga, Rajesh T. Gandhi, Bernard J.C. Macatangay, John W. Mellors, Deborah McMahon, Catherine Godfrey, Lu Zheng
Publikováno v:
J Infect Dis
Background Romidepsin (RMD) is a histone deacetylase inhibitor reported to reverse HIV-1 latency. We sought to identify doses of RMD that were safe and induced HIV-1 expression. Methods Enrollees had HIV-1 RNA Results In the single-dose cohorts 1–3
Autor:
Jeannette Y. Lee, Ishwori Dhakal, Corey Casper, Ariela Noy, Joel M. Palefsky, Missak Haigentz, Susan E. Krown, Richard F. Ambinder, Ronald T. Mitsuyasu
Publikováno v:
Journal of Cancer Epidemiology, Vol 2016 (2016)
The objective of this study was to explore the cancer incidence rates among HIV-infected persons with commercial insurance who were on antiretroviral therapy and compare them with those rates in the general population. Paid health insurance claims fo
Externí odkaz:
https://doaj.org/article/142a5d34e8e14e6f9bce3833f893e5e7
Autor:
Bayard L. Powell, Kieron Dunleavy, Michelle A. Fanale, Philip J. Bierman, David Peace, Andrea Nicole Lucas, Jeremy S. Abramson, Wyndham H. Wilson, Christopher Melani, Stefania Pittaluga, Peter R. Watson, Seth M. Steinberg, Wahid Hanna, Brad S. Kahl, Elaine S. Jaffe, Mark Roschewski, Brian K. Link, Nancy L. Bartlett, Richard F. Little, Ariela Noy, Deepa Jagadeesh, Jonathan W. Friedberg, Prapti A. Patel, Ronald T. Mitsuyasu
Publikováno v:
J Clin Oncol
PURPOSE Burkitt lymphoma is an aggressive B-cell lymphoma curable with dose-intensive chemotherapy derived from pediatric leukemia regimens. Treatment is acutely toxic with late sequelae. We hypothesized that dose-adjusted etoposide, doxorubicin, cyc
Autor:
Ethel Cesarman, Jeannette Y. Lee, Joseph A. Sparano, Juan Carlos Ramos, Ronald T. Mitsuyasu, Ariela Noy, William Wachsman, Amy Chadburn, David H. Henry, Richard F. Ambinder, Lawrence D. Kaplan, Lee Ratner, David M. Aboulafia
Publikováno v:
Haematologica. 106:730-735
Introduction: Six cycles of rituximab plus infusional EPOCH is considered a preferred regimen for first-line treatment of HIV-associated diffuse large B-cell lymphoma (DLBCL), HHV8-positive DLBCL, and primary effusion lymphoma, and is among the prefe
Autor:
Mark A. Dickson, Dirk P. Dittmer, Richard F. Ambinder, Ronald T. Mitsuyasu, Shelly Lensing, Erin Reid, David M. Aboulafia, Frank Maldarelli, Adrienne Suazo, William Wachsman, Robert J. Gorelick
Publikováno v:
Clin Cancer Res
Clinical cancer research : an official journal of the American Association for Cancer Research, vol 26, iss 3
Clinical cancer research : an official journal of the American Association for Cancer Research, vol 26, iss 3
Purpose: AIDS-related Kaposi sarcoma is often incompletely controlled, requiring serial therapies. Kaposi sarcoma herpesvirus (KSHV) induces transformation of endothelial cells, where it resides in a predominately latent state. We hypothesized protea
Autor:
Di Chang, Richard F. Ambinder, Otoniel Martinez-Maza, Shelly Lensing, Larry Magpantay, Laura E. Martínez, Ronald T. Mitsuyasu, Marta Epeldegui, Joseph A. Sparano
Publikováno v:
Clin Cancer Res
Clinical cancer research : an official journal of the American Association for Cancer Research, vol 27, iss 16
Clinical cancer research : an official journal of the American Association for Cancer Research, vol 27, iss 16
Purpose: AIDS-related non-Hodgkin lymphoma (ARL) is the most common cancer in HIV-infected individuals in the United States and other countries in which HIV-positive persons have access to effective combination antiretroviral therapy (cART). Our prio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5841752c12e0662e3ffb0359dcc778a1
https://europepmc.org/articles/PMC8364886/
https://europepmc.org/articles/PMC8364886/
Autor:
Anthony R Cillo, Supriya Krishnan, Deborah K McMahon, Ronald T Mitsuyasu, Michael F Para, John W Mellors
Publikováno v:
PLoS ONE, Vol 9, Iss 3, p e92118 (2014)
The first cure of HIV-1 infection was achieved through complex, multimodal therapy including myeloablative chemotherapy, total body irradiation, anti-thymocyte globulin, and allogeneic stem cell transplantation with a CCR5 delta32 homozygous donor. T
Externí odkaz:
https://doaj.org/article/6a12ab6c8ba9454c9f701ebaa337d081
Autor:
David M. Aboulafia, Erin Reid, Juan Carlos Ramos, Frank Maldarelli, Ronald T. Mitsuyasu, David Looney, Ethel Cesarman, Jeannette Y. Lee, Sara Yahyaei, Ariela Noy, Richard F. Ambinder, David H. Henry, Joseph A. Sparano, William Wachsman
Publikováno v:
Blood Advances. 2:3618-3626
HIV-associated lymphomas (HALs) have high rates of latent infection by gammaherpesviruses (GHVs). We hypothesized that proteasome inhibition would induce lytic activation of GHVs and inhibit HIV infectivity via preservation of cytidine deaminase APOB
Publikováno v:
Anti-Infective Applications of Interferon-Gamma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dfa417c1f7b4630da26f637aeaa2622b
https://doi.org/10.1201/9781003066903-4
https://doi.org/10.1201/9781003066903-4